Global TDS (Transdermal Delivery Systems) Market Growth 2024-2030

Publication ID:

LPI08249912

Publication Date:

August 26, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global TDS (Transdermal Delivery Systems) market size is projected to grow from US$ 14730 million in 2023 to US$ 18650 million in 2030; it is expected to grow at a CAGR of 3.4% from 2024 to 2030.
The 鈥淭DS (Transdermal Delivery Systems) Industry Forecast鈥� looks at past sales and reviews total world TDS (Transdermal Delivery Systems) sales in 2023, providing a comprehensive analysis by region and market sector of projected TDS (Transdermal Delivery Systems) sales for 2024 through 2030. With TDS (Transdermal Delivery Systems) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TDS (Transdermal Delivery Systems) industry.
This Insight Report provides a comprehensive analysis of the global TDS (Transdermal Delivery Systems) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TDS (Transdermal Delivery Systems) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global TDS (Transdermal Delivery Systems) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TDS (Transdermal Delivery Systems) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TDS (Transdermal Delivery Systems).
As the demand for convenient drug delivery systems, improved patient adherence, and enhanced safety profiles continues to rise, the global market for TDS is expected to expand. Manufacturers will likely focus on product innovation, expanding the range of available drugs, improving adhesive properties, and optimizing drug release profiles to meet the evolving needs of patients and healthcare providers seeking effective transdermal medication options.
This report presents a comprehensive overview, market shares, and growth opportunities of TDS (Transdermal Delivery Systems) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
IBSA Group
Teikoku Seiyaku
Amarin Technologies
Key Questions Addressed in this Report
What is the 10-year outlook for the global TDS (Transdermal Delivery Systems) market?
What factors are driving TDS (Transdermal Delivery Systems) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TDS (Transdermal Delivery Systems) market opportunities vary by end market size?
How does TDS (Transdermal Delivery Systems) break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global TDS (Transdermal Delivery Systems) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TDS (Transdermal Delivery Systems) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TDS (Transdermal Delivery Systems) by Country/Region, 2019, 2023 & 2030
2.2 TDS (Transdermal Delivery Systems) Segment by Type
2.2.1 Single-layer Drug-in-Adhesive
2.2.2 Multi-layer Drug-in-Adhesive
2.2.3 Others
2.3 TDS (Transdermal Delivery Systems) Sales by Type
2.3.1 Global TDS (Transdermal Delivery Systems) Sales Market Share by Type (2019-2024)
2.3.2 Global TDS (Transdermal Delivery Systems) Revenue and Market Share by Type (2019-2024)
2.3.3 Global TDS (Transdermal Delivery Systems) Sale Price by Type (2019-2024)
2.4 TDS (Transdermal Delivery Systems) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 TDS (Transdermal Delivery Systems) Sales by Application
2.5.1 Global TDS (Transdermal Delivery Systems) Sale Market Share by Application (2019-2024)
2.5.2 Global TDS (Transdermal Delivery Systems) Revenue and Market Share by Application (2019-2024)
2.5.3 Global TDS (Transdermal Delivery Systems) Sale Price by Application (2019-2024)
3 Global TDS (Transdermal Delivery Systems) by Company
3.1 Global TDS (Transdermal Delivery Systems) Breakdown Data by Company
3.1.1 Global TDS (Transdermal Delivery Systems) Annual Sales by Company (2019-2024)
3.1.2 Global TDS (Transdermal Delivery Systems) Sales Market Share by Company (2019-2024)
3.2 Global TDS (Transdermal Delivery Systems) Annual Revenue by Company (2019-2024)
3.2.1 Global TDS (Transdermal Delivery Systems) Revenue by Company (2019-2024)
3.2.2 Global TDS (Transdermal Delivery Systems) Revenue Market Share by Company (2019-2024)
3.3 Global TDS (Transdermal Delivery Systems) Sale Price by Company
3.4 Key Manufacturers TDS (Transdermal Delivery Systems) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TDS (Transdermal Delivery Systems) Product Location Distribution
3.4.2 Players TDS (Transdermal Delivery Systems) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for TDS (Transdermal Delivery Systems) by Geographic Region
4.1 World Historic TDS (Transdermal Delivery Systems) Market Size by Geographic Region (2019-2024)
4.1.1 Global TDS (Transdermal Delivery Systems) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TDS (Transdermal Delivery Systems) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TDS (Transdermal Delivery Systems) Market Size by Country/Region (2019-2024)
4.2.1 Global TDS (Transdermal Delivery Systems) Annual Sales by Country/Region (2019-2024)
4.2.2 Global TDS (Transdermal Delivery Systems) Annual Revenue by Country/Region (2019-2024)
4.3 Americas TDS (Transdermal Delivery Systems) Sales Growth
4.4 APAC TDS (Transdermal Delivery Systems) Sales Growth
4.5 Europe TDS (Transdermal Delivery Systems) Sales Growth
4.6 Middle East & Africa TDS (Transdermal Delivery Systems) Sales Growth
5 Americas
5.1 Americas TDS (Transdermal Delivery Systems) Sales by Country
5.1.1 Americas TDS (Transdermal Delivery Systems) Sales by Country (2019-2024)
5.1.2 Americas TDS (Transdermal Delivery Systems) Revenue by Country (2019-2024)
5.2 Americas TDS (Transdermal Delivery Systems) Sales by Type
5.3 Americas TDS (Transdermal Delivery Systems) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TDS (Transdermal Delivery Systems) Sales by Region
6.1.1 APAC TDS (Transdermal Delivery Systems) Sales by Region (2019-2024)
6.1.2 APAC TDS (Transdermal Delivery Systems) Revenue by Region (2019-2024)
6.2 APAC TDS (Transdermal Delivery Systems) Sales by Type
6.3 APAC TDS (Transdermal Delivery Systems) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe TDS (Transdermal Delivery Systems) by Country
7.1.1 Europe TDS (Transdermal Delivery Systems) Sales by Country (2019-2024)
7.1.2 Europe TDS (Transdermal Delivery Systems) Revenue by Country (2019-2024)
7.2 Europe TDS (Transdermal Delivery Systems) Sales by Type
7.3 Europe TDS (Transdermal Delivery Systems) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa TDS (Transdermal Delivery Systems) by Country
8.1.1 Middle East & Africa TDS (Transdermal Delivery Systems) Sales by Country (2019-2024)
8.1.2 Middle East & Africa TDS (Transdermal Delivery Systems) Revenue by Country (2019-2024)
8.2 Middle East & Africa TDS (Transdermal Delivery Systems) Sales by Type
8.3 Middle East & Africa TDS (Transdermal Delivery Systems) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TDS (Transdermal Delivery Systems)
10.3 Manufacturing Process Analysis of TDS (Transdermal Delivery Systems)
10.4 Industry Chain Structure of TDS (Transdermal Delivery Systems)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TDS (Transdermal Delivery Systems) Distributors
11.3 TDS (Transdermal Delivery Systems) Customer
12 World Forecast Review for TDS (Transdermal Delivery Systems) by Geographic Region
12.1 Global TDS (Transdermal Delivery Systems) Market Size Forecast by Region
12.1.1 Global TDS (Transdermal Delivery Systems) Forecast by Region (2025-2030)
12.1.2 Global TDS (Transdermal Delivery Systems) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TDS (Transdermal Delivery Systems) Forecast by Type
12.7 Global TDS (Transdermal Delivery Systems) Forecast by Application
13 Key Players Analysis
13.1 Adhex Pharma
13.1.1 Adhex Pharma Company Information
13.1.2 Adhex Pharma TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.1.3 Adhex Pharma TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Adhex Pharma Main Business Overview
13.1.5 Adhex Pharma Latest Developments
13.2 Harro Hofliger
13.2.1 Harro Hofliger Company Information
13.2.2 Harro Hofliger TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.2.3 Harro Hofliger TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Harro Hofliger Main Business Overview
13.2.5 Harro Hofliger Latest Developments
13.3 Tesa Labtec
13.3.1 Tesa Labtec Company Information
13.3.2 Tesa Labtec TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.3.3 Tesa Labtec TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Tesa Labtec Main Business Overview
13.3.5 Tesa Labtec Latest Developments
13.4 Toyochem
13.4.1 Toyochem Company Information
13.4.2 Toyochem TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.4.3 Toyochem TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Toyochem Main Business Overview
13.4.5 Toyochem Latest Developments
13.5 IBSA Group
13.5.1 IBSA Group Company Information
13.5.2 IBSA Group TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.5.3 IBSA Group TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 IBSA Group Main Business Overview
13.5.5 IBSA Group Latest Developments
13.6 Teikoku Seiyaku
13.6.1 Teikoku Seiyaku Company Information
13.6.2 Teikoku Seiyaku TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.6.3 Teikoku Seiyaku TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Teikoku Seiyaku Main Business Overview
13.6.5 Teikoku Seiyaku Latest Developments
13.7 Amarin Technologies
13.7.1 Amarin Technologies Company Information
13.7.2 Amarin Technologies TDS (Transdermal Delivery Systems) Product Portfolios and Specifications
13.7.3 Amarin Technologies TDS (Transdermal Delivery Systems) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Amarin Technologies Main Business Overview
13.7.5 Amarin Technologies Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂